Progress in the treatment of Helicobacter pylori infection / 中南大学学报(医学版)
Journal of Central South University(Medical Sciences)
; (12): 981-988, 2014.
Article
in Zh
| WPRIM
| ID: wpr-815501
Responsible library:
WPRO
ABSTRACT
Helicobacter pylori (H. pylori) infection is highly associated with the occurrence of gastrointestinal diseases, including gastric inflammation, peptic ulcer, gastric mucosa-associated lymphoid-tissue lymphoma and gastric cancer. It is a key strategy to prevent and treat these diseases by eradicating H. pylori. Due to the increasing rates of antimicrobial resistance of clarithromycin and metronidazole, the eradication rate of standard triple therapy is less than 80% in recent years. On the basis of traditional triple therapy, combination with some treatments, such as probiotics, mucoprotective agents, Chinese medicine and oral clean, can improve the H. pylori eradication rate.
Full text:
1
Index:
WPRIM
Main subject:
Peptic Ulcer
/
Stomach Neoplasms
/
Lymphoma, Non-Hodgkin
/
Drugs, Chinese Herbal
/
Helicobacter pylori
/
Helicobacter Infections
/
Clarithromycin
/
Probiotics
/
Therapeutic Uses
/
Drug Therapy
Limits:
Humans
Language:
Zh
Journal:
Journal of Central South University(Medical Sciences)
Year:
2014
Type:
Article